Loblaw Companies Limited (TSE:L – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is C$134.50.
A number of equities research analysts have issued reports on L shares. TD Securities lifted their target price on shares of Loblaw Companies from C$63.00 to C$65.00 in a research note on Thursday, November 13th. Scotiabank lifted their price objective on Loblaw Companies from C$61.00 to C$65.00 and gave the company an “outperform” rating in a research report on Thursday, August 21st. BMO Capital Markets boosted their target price on Loblaw Companies from C$57.50 to C$63.00 in a research note on Thursday, November 13th. CIBC raised their price target on Loblaw Companies from C$58.50 to C$67.00 in a research note on Thursday, November 13th. Finally, National Bankshares lifted their price target on Loblaw Companies from C$60.00 to C$61.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd.
Check Out Our Latest Stock Analysis on Loblaw Companies
Loblaw Companies Price Performance
Loblaw Companies Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Wednesday, October 1st were paid a $0.5643 dividend. The ex-dividend date was Monday, September 15th. This represents a $2.26 dividend on an annualized basis and a yield of 3.7%. Loblaw Companies’s payout ratio is 26.31%.
About Loblaw Companies
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Featured Articles
- Five stocks we like better than Loblaw Companies
- How to Short Nasdaq: An Easy-to-Follow Guide
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- The 3 Best Fintech Stocks to Buy Now
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.
